Home › Funds › BAKER BROS. ADVISORS LP › IMVT

BAKER BROS. ADVISORS LP position in IMVT

IMMUNOVANT INC COM · Health Care

BAKER BROS. ADVISORS LP reported holding 5,435,220 shares of IMVT (IMMUNOVANT INC COM) in its Q2 2026 13F filing — a position valued at US$209.4M, representing 1.09% of its reported portfolio and ranking #15 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.44M sh
Reported value held$209.42M
Portfolio Weight1.09%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's IMVT position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in IMVT in Q3 2023 at 425,009 shares (US$16.3M). The position peaked in Q2 2026 at 5,435,220 shares, worth US$209.4M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 5,435,220 shares valued at US$209.4M. Notable position changes include a 164% increase in Q3 2024 (shares fell 13% over the following quarter), a 39% increase in Q4 2024 (shares fell 31% over the following quarter), a 220% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 425.01K $16.32M New
Q4 2023 425.01K $17.91M Hold
Q1 2024 425.01K $13.73M Hold
Q2 2024 464.72K $12.27M Add
Q3 2024 1.23M $34.94M Add
Q4 2024 1.71M $42.30M Add
Q1 2025 5.46M $93.28M Add
Q2 2025 5.46M $87.33M Hold
Q3 2025 5.46M $87.98M Hold
Q4 2025 5.46M $138.74M Hold
Q1 2026 5.46M $135.57M Hold
Q2 2026 5.44M $209.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMVT and 13F data

IMVT (IMMUNOVANT INC COM) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMVT

All IMVT fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held IMVT?

BAKER BROS. ADVISORS LP has disclosed IMVT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in IMVT?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 5.44M shares of IMVT (IMMUNOVANT INC COM), valued at $209.42M, representing 1.09% of its reported portfolio and ranking #15.

Has BAKER BROS. ADVISORS LP been buying or selling IMVT?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in IMVT. The position peaked in Q2 2026 at 5.44M shares.

Which other funds hold IMVT?

Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.